Fungal infections are growing more common, at a rate the authors call alarming; they link this directly to the rising number of people whose immune systems are impaired.
Management of the fungal infections and challenges associated with it
Ashwini Gayke, Ismail Moazzam
- Editor approved · 16 Nov 2026
- December 2023
- DOI 10.56511/jipbs.2023.10402
The question
Why are fungal infections a growing challenge, and what stands in the way of treating them?
- Fungal infections are growing more common, at a rate the authors call alarming.
- The authors link this growth directly to there being more people whose immune systems are impaired.
What was done
- The article describes superficial and subcutaneous fungal infections, which affect the skin, keratinous tissues and mucous membranes.
- It looks at the available antifungal drugs, with which several superficial and systemic diseases are treated.
- It sets out how fungal resistance arises and why new treatments are needed.
Key findings
Changes in medical practice, including immunosuppressive medications and intense chemotherapy, lie behind the rise in impaired immunity; HIV and other immunity-impairing illnesses have played a part as well.
Superficial and subcutaneous fungal infections are rarely life-threatening, but they can have crippling effects on quality of life and, in some cases, can become invasive or pass to other people.
Fungi resist most antifungal medicines - the evidence for this is well established - which complicates antifungal therapy and makes it hard to control disease. The resistance arises from physiological and genetic alterations and from selection when antifungal drugs are present.
The authors give three main reasons why novel therapeutics and other approaches are needed: antifungal drugs do not come in a wide range, resistance builds up, and biofilms confer resistance.
Why it matters
- The authors hold that novel therapeutics and other approaches are needed to improve treatment outcomes against mycoses.
- Because fungi resist most antifungal medicines, controlling disease is challenging.
- Fungal pathogens use several tactics to weaken the host’s immune system and escalate infections.
How to cite
Ashwini Gayke, Ismail Moazzam. Management of the fungal infections and challenges associated with it. Journal of Innovations in Pharmaceutical and Biological Sciences. 2023;10(04):14-22. https://doi.org/10.56511/jipbs.2023.10402
- The article at doi.org (the publisher's page and PDF)
- The article on the journal's site
- The journal at the ISSN Portal (ISSN 2349-2759)